Concepedia
Statistics
Publications
75
Citations
5.3K
H-Index
34
Active since
1997
Affiliations
Fred Hutch Cancer Center(Current)
University of Washington
University of Washington Medical Center
Cancer Research Center
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Brian G. Till is an author at Fred Hutch Cancer Center specializing in oncology, immunotherapy, and cancer immunotherapy.
Publications per year
1997–2025
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2008 · 719 citations · Full text
Life Sciences, Immunology, Oncology +17
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2012 · 530 citations
Medicine, Immunology, Oncology +17
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Kevin A. Hay, Jordan Gauthier, Alexandre V. Hirayama et al. · Blood · 2019 · 401 citations · Full text
Life Sciences, Immunology, Oncology +13
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay et al. · Blood · 2019 · 336 citations · Full text
Life Sciences, Immunology, Oncology +14
Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane
Scott E. James, Philip D. Greenberg, Michael C. Jensen et al. · The Journal of Immunology · 2008 · 251 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
1–5 of 75